Lineage Cell Therapeutics
LCTX
#8800
Rank
โ‚น9.37 B
Marketcap
โ‚น42.55
Share price
0.93%
Change (1 day)
-51.66%
Change (1 year)

Lineage Cell Therapeutics (LCTX) - Cash on Hand

Cash on Hand as of September 2024 : โ‚น2.77 Billion

According to Lineage Cell Therapeutics 's latest financial reports the company has โ‚น2.77 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Lineage Cell Therapeutics - Cash on Hand chart (from 1996 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31โ‚น2.95 B-38.31%
2022-12-31โ‚น4.78 B10.26%
2021-12-31โ‚น4.34 B42.9%
2020-12-31โ‚น3.03 B38.77%
2019-12-31โ‚น2.19 B1.9%
2018-12-31โ‚น2.14 B-11.82%
2017-12-31โ‚น2.43 B57.91%
2016-12-31โ‚น1.54 B-45.96%
2015-12-31โ‚น2.85 B52.83%
2014-12-31โ‚น1.86 B450.5%
2013-12-31โ‚น0.33 B42.55%
2012-12-31โ‚น0.23 B-79.73%
2011-12-31โ‚น1.17 B-21.31%
2010-12-31โ‚น1.49 B164.03%
2009-12-31โ‚น0.56 B95729.02%
2008-12-31โ‚น0.59 M58.28%
2007-12-31โ‚น0.37 M-98.5%
2006-12-31โ‚น24.84 M-69.89%
2005-12-31โ‚น82.51 M39%
2004-12-31โ‚น59.36 M81.8%
2003-12-31โ‚น32.65 M-46.99%
2002-12-31โ‚น61.59 M-22.76%
2001-12-31โ‚น79.74 M29.61%
2000-12-31โ‚น61.52 M-73.26%
1999-12-31โ‚น0.23 B125.48%
1998-12-31โ‚น0.10 B
1998-06-30โ‚น0.17 B-37.69%
1997-06-30โ‚น0.27 B231.94%
1996-06-30โ‚น84.23 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
โ‚น23.10 B 732.65%๐Ÿ‡บ๐Ÿ‡ธ USA